Agenus to participate in september investor conferences

Lexington, mass.lexington, mass.--(business wire)--agenus inc. (“agenus”) (nasdaq: agen), a leader in developing novel immunological agents to treat various cancers, today announced that dr. garo armen, chairman and ceo, will participate in the following upcoming investor conferences: 2023 wells fargo healthcare conference – fireside chat presentation will be held in-person on thursday, september 7th, 2023, at 11:00 a.m. et in boston, ma. a live webcast and replay will be accessible on the comp.
AGEN Ratings Summary
AGEN Quant Ranking